Drugs / B-cell vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07422896 | Sep 2026 → Sep 2028 expected | glioblastoma | Catalina Lee Chang | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | B-cell vaccine | “B-cell vaccine (Bvax)” NCT07422896 ↗ |
| Known as | Bvax | “B-cell vaccine (Bvax)” NCT07422896 ↗ |
| Modality | Vaccine | “B-cell vaccine (Bvax)” NCT07422896 ↗ |